CWM
SGMO

Cedar Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Cedar Wealth Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,270
Closed -$154K – 170
2019
Q2 		$154K Hold
14,270
– – 0.1% 75
2019
Q1 		$136K Hold
14,270
– – 0.09% 74
2018
Q4 		$164K Hold
14,270
– – 0.12% 58
2018
Q3 		$242K Buy
+14,270
New +$217K 0.13% 51

Other funds holding SGMO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cedar Wealth Management's SGMO Position: Q3 2019 in Review

Cedar Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2019, closing a stake of 14,270 shares — an estimated $154K sold.

Cedar Wealth Management first reported a position in SGMO in Q3 2018 and held it in 4 quarters. The position peaked at $242K in Q3 2018. 184 funds tracked by Wall St. Rank hold SGMO as of Q3 2019.

  • Cedar Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2019 after selling out during the quarter.
  • Cedar Wealth Management sold 14,270 SANGAMO THERAPEUTICS INC shares in Q3 2019, an estimated $154K.
  • Cedar Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2018 and held it in 4 quarters.
  • Cedar Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $242K in Q3 2018.
  • 184 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2019.

Based on Cedar Wealth Management's 13F filing for Q3 2019, filed 24 Oct 2019.